Angola vs Eastern Mediterranean (WHO region): Hepatitis B surface antigen (HBsAg) prevalence (%)
Angola
3.1%
in 2024
Eastern Mediterranean (WHO region)
0.5%
in 2024
Angola rank
5th
Eastern Mediterranean (WHO region) rank
4th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Angola
- Eastern Mediterranean (WHO region)
How they compare
Angola currently reports 3.1% against 0.5% in Eastern Mediterranean (WHO region), a difference of 2.6%.
That makes Angola's figure about 6.2 times Eastern Mediterranean (WHO region)'s.
Across all 10 years both countries report, Angola has been ahead every year.
Angola ranks 5th and Eastern Mediterranean (WHO region) ranks 4th of 194 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.6% | 2.1% | Angola |
| 2020s | 3.0% | 0.5% | 2.5% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Angola or Eastern Mediterranean (WHO region)?
- Angola, at 3.1% against 0.5% in Eastern Mediterranean (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Angola and Eastern Mediterranean (WHO region)?
- 2.6%, with Angola ahead.
- How many years of comparable data are there for Angola and Eastern Mediterranean (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Eastern Mediterranean (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Angola ranks 5th and Eastern Mediterranean (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.